Amitryptyline, Demethyl- en es it fr

Amitryptyline, Demethyl- Brand names, Amitryptyline, Demethyl- Analogs

Amitryptyline, Demethyl- Brand Names Mixture

  • No information avaliable

Amitryptyline, Demethyl- Chemical_Formula

C19H21N

Amitryptyline, Demethyl- RX_link

http://www.rxlist.com/cgi/generic/nortrip.htm

Amitryptyline, Demethyl- fda sheet

Amitryptyline,_Demethyl- FDA

Amitryptyline, Demethyl- msds (material safety sheet)

Amitryptyline, Demethyl- Synthesis Reference

E. I. Engelhardt, U.S. Pat. 3,922,305 (1975)

Amitryptyline, Demethyl- Molecular Weight

263.377 g/mol

Amitryptyline, Demethyl- Melting Point

213-215oC

Amitryptyline, Demethyl- H2O Solubility

No information avaliable

Amitryptyline, Demethyl- State

Solid

Amitryptyline, Demethyl- LogP

4.298

Amitryptyline, Demethyl- Dosage Forms

Capsules

Amitryptyline, Demethyl- Indication

For the treatment of depression.

Amitryptyline, Demethyl- Pharmacology

Similar to protriptyline, nortriptyline is a tricyclic antidepressant of the dibenzocycloheptene type and is the active metabolite of amitriptyline.

Amitryptyline, Demethyl- Absorption

Well absorbed from the GI tract.

Amitryptyline, Demethyl- side effects and Toxicity

Symptoms of overdose include cardiac dysrhythmias, severe hypotension, shock, congestive heart failure, pulmonary edema, convulsions, and CNS depression, including coma. Changes in the electrocardiogram, particularly in QRS axis or width, are clinically significant indicators of tricyclic antidepressant toxicity. LD50=mg/kg(orally in rat)

Amitryptyline, Demethyl- Patient Information

Amitryptyline, Demethyl- Organisms Affected

Humans and other mammals